Skip to content

Correlation between human epididymal protein-4 biomarkers and the severity and poor prognosis of interstitial lung disease

Correlation between human epididymal protein-4 biomarkers and the severity and poor prognosis of interstitial lung disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400082150
Enrollment
Unknown
Registered
2024-03-21
Start date
2022-01-01
Completion date
Unknown
Last updated
2024-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Interstitial lung disease

Interventions

Interstitial lung disease was not associated with connective tissue disease group:None
Healthy control group:None

Sponsors

Hebei General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
34 Years to 84 Years

Inclusion criteria

Inclusion criteria: Patients diagnosed with interstitial lung disease were included in the inpatients of Hebei General Hospital. Patients with an average age of about 60 years were randomly selected and admitted to hospital to complete chest CT. Patients who consented to serological specimen collection were included in the secondary grouping.

Exclusion criteria

Exclusion criteria: Patients with a history of cancer or malignancy, and significant comorbidities of other organs, such as acute or chronic heart failure, kidney or liver damage (including nephritis, chronic kidney disease, chronic hepatitis, chronic liver disease, and cirrhosis).

Design outcomes

Primary

MeasureTime frame
Human epididymal protein 4;Krebs Von den Lungen-6;

Secondary

MeasureTime frame
FVC%;DLCO%;GAP index;

Countries

China

Contacts

Public ContactLi Yan

Hebei General Hospital

hbghpccmyl@126.com+86 180 3200 6399

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026